Click to view all 6 pages
We did not observe any difference in the SNP effect on side effects for semaglutide versus tirzepatide (Extended Data Fig
The researchers discovered that small-molecule GLP-1 drugs significantly reduced how much dopamine, a neurotransmitter thats commonly associated with reward-motivated behaviors, was released, essentially changing the animals perception of how rewarding that food is. Gler hopes that his teams discovery can help guide future efforts in designing GLP-1 drugs that target specific parts of the brain, such as the reward center
Others prefer to inject on an empty stomach
This is why many individuals feel hungry even after eating, struggle with constant cravings, or feel out of control around food
Our experienced medical providers carefully evaluate each patients medical history, treatment goals, preferences, and potential side effects when recommending the most suitable GLP-1 receptor agonist